Gastrointestinal Stent Uygulamaları: Tek merkez deneyimi

Mustafa Zanyar Akkuzu, Orhan Sezgin, Fehmi Ateş, O. Özdoğan, Serkan Yaraş, Ferzan Aydin, H. Balci, Enver Üçbilek, Engin Altıntaş
{"title":"Gastrointestinal Stent Uygulamaları: Tek merkez deneyimi","authors":"Mustafa Zanyar Akkuzu, Orhan Sezgin, Fehmi Ateş, O. Özdoğan, Serkan Yaraş, Ferzan Aydin, H. Balci, Enver Üçbilek, Engin Altıntaş","doi":"10.17944/MKUTFD.804229","DOIUrl":null,"url":null,"abstract":"Stent Applications: Single Objective: Gastrointestinal (GI) stents are used for palliative purposes in malignant or benign strictures in the gastrointestinal tract and pressure or fistulas associated with neighboring organ malignancies such as lung cancer, or stenosis or leakage after operations. In this study, we aimed to share our clinical experience with GI stents by evaluating the reasons and course of GI stents. Materials and Methods: Patients who had a GI stent in our clinic between 2014 and 2019 were included in the study. Retrospectively, the reason for stent insertion, the type of stent, the presence or absence of complications, the management of the complications and the life span of the patients were analyzed. Especially in advanced stage cancers, the effectiveness of stents in palliative treatment and their contribution to life span were evaluated. Results: During this period, a total of 36 patients had GI stents implanted. 24 (67%) of our patients were male and 12 (33%) were female. The mean age of men was 67 ± 13.8, and the mean age of women was 45.6 ± 11.5. Those who are stented for malign reasons; A stent was implanted for 44.5% esophageal cancer, 19.5% stomach cancer, 16.6% lung cancer and 5.5% rectal cancer. Of those who were stented for benign reasons, 11.1% had a fistula, and 2.8% had a stent due to stage d esophagitis. SEMS was attached to all of them. 27% of our patients were still alive. 73% of our patients died and when we looked at the average life span, we found it as 109.6 ± 101 days. Conclusion: As a result, it is seen that the use of stents in palliation of patients with inoperable digestive system stenosis is an effective method for a quality palliation in the short term. By using self-expanding metal stents, malignant and benign dysphagia can be alleviated.","PeriodicalId":30746,"journal":{"name":"Mustafa Kemal Universitesi Tip Dergisi","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mustafa Kemal Universitesi Tip Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17944/MKUTFD.804229","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Stent Applications: Single Objective: Gastrointestinal (GI) stents are used for palliative purposes in malignant or benign strictures in the gastrointestinal tract and pressure or fistulas associated with neighboring organ malignancies such as lung cancer, or stenosis or leakage after operations. In this study, we aimed to share our clinical experience with GI stents by evaluating the reasons and course of GI stents. Materials and Methods: Patients who had a GI stent in our clinic between 2014 and 2019 were included in the study. Retrospectively, the reason for stent insertion, the type of stent, the presence or absence of complications, the management of the complications and the life span of the patients were analyzed. Especially in advanced stage cancers, the effectiveness of stents in palliative treatment and their contribution to life span were evaluated. Results: During this period, a total of 36 patients had GI stents implanted. 24 (67%) of our patients were male and 12 (33%) were female. The mean age of men was 67 ± 13.8, and the mean age of women was 45.6 ± 11.5. Those who are stented for malign reasons; A stent was implanted for 44.5% esophageal cancer, 19.5% stomach cancer, 16.6% lung cancer and 5.5% rectal cancer. Of those who were stented for benign reasons, 11.1% had a fistula, and 2.8% had a stent due to stage d esophagitis. SEMS was attached to all of them. 27% of our patients were still alive. 73% of our patients died and when we looked at the average life span, we found it as 109.6 ± 101 days. Conclusion: As a result, it is seen that the use of stents in palliation of patients with inoperable digestive system stenosis is an effective method for a quality palliation in the short term. By using self-expanding metal stents, malignant and benign dysphagia can be alleviated.
胃肠支架的应用:一个中心实验
支架应用:单一目的:胃肠道(GI)支架用于缓解胃肠道的恶性或良性狭窄以及与邻近器官恶性肿瘤(如肺癌)相关的压力或瘘,或手术后狭窄或渗漏。在这项研究中,我们旨在通过评估胃肠道支架的原因和过程来分享我们的临床经验。材料与方法:纳入2014年至2019年在我院门诊接受胃肠道支架治疗的患者。回顾性分析患者置入术的原因、支架的类型、并发症的有无、并发症的处理及患者的生存期。特别是在晚期癌症中,支架在姑息治疗中的有效性及其对寿命的贡献被评估。结果:在此期间,共36例患者植入了胃肠道支架。其中男性24例(67%),女性12例(33%)。男性平均年龄67±13.8岁,女性平均年龄45.6±11.5岁。因恶性原因被支架的;食管癌为44.5%,胃癌为19.5%,肺癌为16.6%,直肠癌为5.5%。在因良性原因植入支架的患者中,11.1%的患者有瘘,2.8%的患者因d期食管炎而植入支架。他们身上都附有SEMS。27%的病人仍然活着。73%的患者死亡,当我们观察平均寿命时,我们发现它是109.6±101天。结论:可见支架在不能手术消化系统狭窄患者中的应用是一种短期内质量缓解的有效方法。通过使用自膨胀的金属支架,可以减轻恶性和良性吞咽困难。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
29
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信